Pages that link to "Q35629243"

The following pages link to Therapeutic siRNAs (Q35629243):

Displaying 45 items.

• Advanced glycation endproduct (AGE) receptor 1 is a negative regulator of the inflammatory response to AGE in mesangial cells (Q24563997) (← links)
• RNA interference and potential therapeutic applications of short interfering RNAs (Q28250480) (← links)
• Simultaneous silencing of Npy and Dbh expression in hindbrain A1/C1 catecholamine cells suppresses glucoprivic feeding (Q28581763) (← links)
• Oligonucleotide-based antiviral strategies. (Q30353665) (← links)
• Clinical translation of genotyping and haplotyping data: implementation of in vivo pharmacology experience leading drug prescription to pharmacotyping (Q31128049) (← links)
• Isolation of peptides blocking the function of anti-apoptotic Livin protein (Q33533589) (← links)
• Uptake and transfection efficiency of PEGylated cationic liposome-DNA complexes with and without RGD-tagging (Q33654083) (← links)
• Mouse neuronal cells expressing exogenous bovine PRNP and simultaneous downregulation of endogenous mouse PRNP using siRNAs (Q33772925) (← links)
• Cationic liposome-nucleic acid complexes for gene delivery and gene silencing. (Q34889277) (← links)
• Gene Therapy for Head and Neck Squamous Cell Carcinoma Using KITENIN (KAI1 COOH-Terminal Interacting Tetraspanin)-Antisense Therapy (Q35003287) (← links)
• Nanogyroids Incorporating Multivalent Lipids: Enhanced Membrane Charge Density and Pore Forming Ability for Gene Silencing (Q35058472) (← links)
• Inhibition of ocular angiogenesis by siRNA targeting vascular endothelial growth factor pathway genes: therapeutic strategy for herpetic stromal keratitis (Q35103511) (← links)
• Fluorescence microscopy colocalization of lipid-nucleic acid nanoparticles with wildtype and mutant Rab5-GFP: A platform for investigating early endosomal events (Q35434767) (← links)
• Stromal cell-derived CSF-1 blockade prolongs xenograft survival of CSF-1-negative neuroblastoma (Q35568697) (← links)
• Hydrophobization and bioconjugation for enhanced siRNA delivery and targeting (Q35697443) (← links)
• Glycomics: a pathway to a class of new and improved therapeutics (Q35906116) (← links)
• The design and exogenous delivery of siRNA for post-transcriptional gene silencing. (Q35950928) (← links)
• Cationic liposome-nucleic acid complexes: liquid crystal phases with applications in gene therapy (Q36079742) (← links)
• Gene therapy for obesity (Q36099461) (← links)
• On the delivery of small interfering RNAs into mammalian cells (Q36316859) (← links)
• Inhibitors of signal transduction protein kinases as targets for cancer therapy (Q36625236) (← links)
• Systems cell biology based on high-content screening (Q36655541) (← links)
• Characterization of binding sites of eukaryotic transcription factors (Q37318155) (← links)
• Cationic liposome-nucleic acid complexes for gene delivery and silencing: pathways and mechanisms for plasmid DNA and siRNA. (Q37403081) (← links)
• Dendritic Cells Loaded with Tumor Antigens and a Dual Immunostimulatory and Anti-Interleukin 10-Specific Small Interference RNA Prime T Lymphocytes against Leukemic Cells. (Q37429846) (← links)
• Liquid crystal assemblies in biologically inspired systems (Q37591036) (← links)
• Chemically Programmed Polymers for Targeted DNA and siRNA Transfection (Q37866741) (← links)
• DNA-surfactant complexes: self-assembly properties and applications. (Q38661318) (← links)
• Effects of SARA on oxygen-glucose deprivation in PC12 cell line (Q39188710) (← links)
• RNA Interference Inhibits High Mobility Group Box 1 by Lipopolysaccharide-Activated Murine Macrophage RAW 264.7 Secretion (Q39563281) (← links)
• Highly efficient gene silencing activity of siRNA embedded in a nanostructured gyroid cubic lipid matrix. (Q39638881) (← links)
• Silencing of the MYCN gene by siRNA delivered by folate receptor-targeted liposomes in LA-N-5 cells (Q39663641) (← links)
• Inhibition of MDR1 gene expression by chimeric HNA antisense oligonucleotides (Q39946545) (← links)
• Reconstituted influenza virus envelopes as an efficient carrier system for cellular delivery of small-interfering RNAs. (Q40355127) (← links)
• Molecular basis for the immunostimulatory potency of small interfering RNAs (Q41065608) (← links)
• Diseases originate and terminate by genes: unraveling nonviral gene delivery (Q41197665) (← links)
• TNFalpha siRNA reduces brain TNF and EEG delta wave activity in rats (Q42080971) (← links)
• Modulation of dendritic cell maturation and function with mono- and bifunctional small interfering RNAs targeting indoleamine 2,3-dioxygenase (Q43279090) (← links)
• RNAi therapy: antibodies guide the way. (Q45865381) (← links)
• Inhibition of gene expression in mice muscle by in vivo electrically mediated siRNA delivery. (Q45880001) (← links)
• Discovery of the DIGIRR Gene from Teleost Fish: A Novel Toll–IL-1 Receptor Family Member Serving as a Negative Regulator of IL-1 Signaling (Q47073356) (← links)
• miRNA and Dicer in the mammalian lens: expression of brain-specific miRNAs in the lens. (Q54623735) (← links)
• The use of small interfering RNA to elucidate the activity and function of ion channel genes in an intact tissue (Q81701209) (← links)
• Single-stranded small interfering RNA are more immunostimulatory than their double-stranded counterparts: a central role for 2'-hydroxyl uridines in immune responses (Q83145000) (← links)
• Design, mechanism, delivery and therapeutics of canonical and Dicer-substrate siRNA (Q89910193) (← links)